Cargando…

Number of endoscopic sessions to eradicate varices identifies high risk of rebleeding in cirrhotic patients

BACKGROUND AND AIMS: Risk stratification to identify patients with high risk of variceal rebleeding is particularly important in patients with decompensated cirrhosis. In clinical practice, eliminating gastroesphageal varices thoroughly after sequential endoscopic treatment reduces the rebleeding ra...

Descripción completa

Detalles Bibliográficos
Autores principales:	Guo, Huiwen, Zhang, Ming, Zhang, Na, Yin, Xiaochun, Cheng, Yang, Gu, Lihong, Wang, Xixuan, Xiao, Jiangqiang, Wang, Yi, Zou, Xiaoping, Zhuge, Yuzheng, Zhang, Feng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9063156/ https://www.ncbi.nlm.nih.gov/pubmed/35505293 http://dx.doi.org/10.1186/s12876-022-02283-0

Ejemplares similares

Increase in Free Hepatic Venous Pressure Response to Beta-Blockers Predicts Variceal Bleeding in Cirrhotic Patients
por: Guo, Huiwen, et al.
Publicado: (2021)

Dose-dependent effect of propranolol on the hemodynamic response in cirrhotic patients with gastroesophageal varices
por: Zhang, Feng, et al.
Publicado: (2019)

A nomogram to predict the risk of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt in Cirrhotic Patients
por: Yin, Xiaochun, et al.
Publicado: (2020)

Overweight/Obesity Increases the Risk of Overt Hepatic Encephalopathy after Transjugular Intrahepatic Portosystemic Shunt in Cirrhotic Patients
por: Gu, Lihong, et al.
Publicado: (2023)

Agreement between Wedged Hepatic Venous Pressure and Portal Pressure in Hepatic Sinusoidal Obstruction Syndrome
por: Cheng, Yang, et al.
Publicado: (2022)

Spleen Stiffness Predicts Survival after Transjugular Intrahepatic Portosystemic Shunt in Cirrhotic Patients
por: Zhu, Hao, et al.
Publicado: (2020)

PTFE-covered TIPS is an effective treatment for secondary preventing variceal rebleeding in cirrhotic patients with high risks
por: Zhou, Yongjie, et al.
Publicado: (2020)

Covered TIPS Procedure-Related Major Complications: Incidence, Management and Outcome From a Single Center
por: Yin, Xiaochun, et al.
Publicado: (2022)

Emergency endoscopic variceal ligation in cirrhotic patients with blood clots in the stomach but no active bleeding or stigmata increases the risk of rebleeding
por: Kim, Su Jin, et al.
Publicado: (2016)

CT-Based Radiomics Score Can Accurately Predict Esophageal Variceal Rebleeding in Cirrhotic Patients
por: Meng, Dongxiao, et al.
Publicado: (2021)

Long-term Outcomes of Endoscopic Variceal Ligation to Prevent Rebleeding in Children with Esophageal Varices
por: Kang, Ki Soo, et al.
Publicado: (2013)

The endoscopic ultrasound probe findings in prediction of esophageal variceal recurrence after endoscopic variceal eradication therapies in cirrhotic patients: a cohort prospective study
por: Zheng, Junfu, et al.
Publicado: (2019)

Aluminum phosphate gel reduces early rebleeding in cirrhotic patients with gastric variceal bleeding treated with histoacryl injection therapy
por: Zeng, Hao-Tian, et al.
Publicado: (2023)

Associations Between Endoscopic Primary Prophylaxis and Rebleeding in Liver Cirrhosis Patients with Esophagogastric Variceal Bleeding
por: Gao, Yanying, et al.
Publicado: (2022)

Effect of Alcohol Consumption on Variceal Rebleeding and Mortality
por: Henderson, J. Michael
Publicado: (1992)

Protective Effect of Probiotics against Esophagogastric Variceal Rebleeding in Patients with Liver Cirrhosis after Endoscopic Therapy
por: Zhang, Qun, et al.
Publicado: (2020)

Albumin‑bilirubin grade and INR for the prediction of esophagogastric variceal rebleeding after endoscopic treatment in cirrhosis
por: Li, Fenghui, et al.
Publicado: (2023)

Transjugular intrahepatic portosystemic shunt for the prevention of variceal rebleeding in cirrhotic patients with portal vein thrombosis: study protocol for a randomised controlled trial
por: Qi, Xingshun, et al.
Publicado: (2013)

Transjugular intrahepatic portosystemic shunt may be superior to conservative therapy for variceal rebleeding in cirrhotic patients with non-tumoral portal vein thrombosis: A hypothesis
por: Qi, Xingshun, et al.
Publicado: (2012)

Characteristics of myeloproliferative neoplasm-associated portal hypertension and endoscopic management of variceal bleeding
por: Huang, Xiaoquan, et al.
Publicado: (2022)

Comparative study for predictability of type 1 gastric variceal rebleeding after endoscopic variceal ligation: High-frequency intraluminal ultrasound study
por: Kim, Jeong Hwan, et al.
Publicado: (2021)

Evaluation of endoscopic variceal band ligation sessions in obliteration of esophageal varices
por: Alvi, Haris, et al.
Publicado: (2020)

Mortality and rebleeding following variceal haemorrhage in liver cirrhosis and periportal fibrosis
por: Mohammed, Sara Elfadil Abbas, et al.
Publicado: (2016)

Clinical algorithms for the prevention of variceal bleeding and rebleeding in patients with liver cirrhosis
por: Pfisterer, Nikolaus, et al.
Publicado: (2021)

Effect of aluminum phosphate gel on prevention of early rebleeding after ligation of esophageal variceal hemorrhage
por: Zhang, Zhu-Liang, et al.
Publicado: (2021)

Variceal bleeding in cirrhotic patients
por: Mallet, Maxime, et al.
Publicado: (2017)

Measurement of Variceal Pressure with a Computerized Endoscopic Manometry: Validation and Effect of Propranolol Therapy in Cirrhotic Patients
por: Kong, De-Run, et al.
Publicado: (2013)

Complete Eradication of Bleeding Duodenal Varices with Endoscopic Polydocanol Sclerotherapy
por: Temel, Tuncer, et al.
Publicado: (2016)

Antibiotic prophylaxis in the prevention of rebleeding in acute variceal hemorrhage: A randomized trial
por: Agarwal, Ajit, et al.
Publicado: (2015)

Carvedilol versus propranolol in the prevention of variceal rebleeding in hepatosplenic schistosomiasis: Efficacy and safety
por: Razafindrazoto, Chantelli Iamblaudiot, et al.
Publicado: (2022)

Partial splenic embolization combined with endoscopic therapies and NSBB decreases the variceal rebleeding rate in cirrhosis patients with hypersplenism: a multicenter randomized controlled trial
por: Sun, Xin, et al.
Publicado: (2021)

Esophageal collateral veins in predicting esophageal variceal recurrence and rebleeding after endoscopic treatment: a systematic review and meta-analysis
por: Li, Qian-Qian, et al.
Publicado: (2020)

A Liver Stiffness Measurement-Based Nomogram Predicts Variceal Rebleeding in Hepatitis B-Related Cirrhosis
por: Liu, Linxiang, et al.
Publicado: (2022)

High-density lipoprotein cholesterol for the prediction of mortality in cirrhosis with portal vein thrombosis: a retrospective study
por: Gao, Bo, et al.
Publicado: (2019)

Transjugular Intrahepatic Portosystemic Shunt With or Without Gastroesophageal Variceal Embolization for the Prevention of Variceal Rebleeding: A Systematic Review and Meta-Analysis
por: Jaber, Fouad, et al.
Publicado: (2023)

Individualized portal pressure gradient threshold based on liver function categories in preventing rebleeding after TIPS
por: Xia, Yifu, et al.
Publicado: (2023)

Use of nonselective β blockers after variceal eradication in cirrhotic patients undergoing secondary prophylaxis of esophageal variceal bleeding: a critical review of current evidence
por: Xu, Xiangbo, et al.
Publicado: (2019)

Defining the advantages and exposing the limitations of endoscopic variceal ligation in controlling acute bleeding and achieving complete variceal eradication
por: Krige, Jake, et al.
Publicado: (2020)

Hepatic venous pressure gradient and rebleeding risk of patients with nonalcoholic steatohepatitis cirrhosis after variceal bleeding
por: Shi, Yiqi, et al.
Publicado: (2023)

Risk of rebleeding from gastroesophageal varices after initial treatment with cyanoacrylate; a systematic review and pooled analysis
por: Hu, Zixuan, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_j74ifc8aqapfkjflf2rljp1c39